Loss of response during long-term treatment of restless legs syndrome: Guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trials

Sleep Medicine

Volumn 11, Issue 9, 2010, Pages 956-957

  Garcia Borreguero, D ^a   Allen, R ^b   Kohnen, R ^c   Benes, H ^d   Winkelman, J ^e   Hogl B ^f   Ferini Strambi, L ^g   Zucconi, M ^g   Trenkwalder, C ^h  

^a SLEEP RESEARCH INSTITUTE   (Spain)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g San Raf faele Institute   (Italy)

^h Paracelsus Elena Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PRAMIPEXOLE;

DRUG EFFICACY; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; THERAPY EFFECT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

CLINICAL TRIALS AS TOPIC; HUMANS; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 79955098329     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2010.08.001     Document Type: Letter

References (4)

1. Winkelman J.W., Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med 2004, 5:9-14.
2. Garcia-Borreguero D., Allen R.P., Kohnen R., et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 2007, 8:520-530.
3. Trenkwalder C., Hogl B., Benes H., Kohnen R. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 2008, 9:572-574.
4. Rottach K.G., Schaner B.M., Kirch M.H., et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008, 43:70-75.